Keyphrases
Serum Concentration
100%
Hot Flashes
100%
Tamoxifen Therapy
33%
Treatment Outcome
16%
Body Mass Index
16%
Postmenopausal Women
16%
Endoxifen
16%
Active Metabolite
8%
Serum Samples
8%
Single nucleotide Polymorphism
8%
Between-person
8%
Recurrence Rate
8%
Cytochrome P450 2D6 (CYP2D6)
8%
Treatment Side Effects
8%
Patient-completed
8%
Mortality Rate
8%
Patient's Will
8%
Confounding Factors
8%
Estradiol Level
8%
Estradiol
8%
Treatment Optimization
8%
Estrogen Receptor-positive Breast Cancer
8%
Tamoxifen Metabolites
8%
4-hydroxytamoxifen
8%
Unadjusted Analyses
8%
Menopausal Status
8%
N-desmethyltamoxifen
8%
Adjuvant Tamoxifen
8%
CYP2D6 Genotype
8%
Oestradiol Concentrations
8%
Biometric Data
8%
Flash Rate
8%
Nursing and Health Professions
Blood Level
100%
Tamoxifen
100%
Hot Flush
100%
Diethylstilbestrol
21%
Body Mass
14%
Treatment Outcome
14%
Endoxifen
14%
CYP2D6
14%
Recurrent Disease
7%
Side Effect
7%
Mortality Rate
7%
Recurrence Risk
7%
Confounding Factor
7%
Biometry
7%
Afimoxifene
7%
Active Metabolite
7%
Nortamoxifen
7%
Estrogen Receptor Positive Breast Cancer
7%
Pharmacology, Toxicology and Pharmaceutical Science
Tamoxifen
100%
Hot Flush
100%
Diethylstilbestrol
21%
Endoxifen
14%
CYP2D6
14%
Active Metabolite
7%
Side Effect
7%
Mortality Rate
7%
Recurrent Disease
7%
Estrogen Receptor Positive Breast Cancer
7%
Recurrence Risk
7%
Afimoxifene
7%
Nortamoxifen
7%
Material Science
Metabolite
100%
Confounding Factor
14%
Agricultural and Biological Sciences